Marrone Bio Innovations, Inc.
MBII
MBII was delisted on the 12th of July, 2022.
22 hedge funds and large institutions have $15.1M invested in Marrone Bio Innovations, Inc. in 2017 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 3 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 4
8% less funds holding
Funds holding: 24 → 22 (-2)
14% less capital invested
Capital invested by funds: $17.5M → $15.1M (-$2.42M)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AAP
Ardsley Advisory Partners
Stamford,
Connecticut
|
+$4.12M |
| 2 |
BlackRock
New York
|
+$103K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$21.2K |
| 4 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
+$2.84K |
| 5 |
FDCDDQ
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
|
+$709 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$37.3K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$36.7K |
| 3 |
Primecap Management
Pasadena,
California
|
-$24.2K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$24K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$22K |
MBII Hedge Fund Activity: Q2 2017 in Review
22 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in Marrone Bio Innovations, Inc. (MBII) for Q2 2017, worth a combined $15.1M — down 14% from $17.5M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of MBII and 1 opened new positions — a net loss of 2 holders — while 4 trimmed existing stakes and 6 added.
The largest buyer was Ardsley Advisory Partners, adding an estimated $4.12M. The largest seller was Bridgeway Capital Management, cutting an estimated $37.3K.
- 22 institutional investors held Marrone Bio Innovations, Inc. (MBII) as of Q2 2017, down from 24 in Q1 2017.
- Funds reported $15.1M of Marrone Bio Innovations, Inc. stock for Q2 2017, down 14% quarter-over-quarter.
- 1 fund opened new Marrone Bio Innovations, Inc. positions in Q2 2017 and 3 closed out, a net change of -2 holders.
- The largest Marrone Bio Innovations, Inc. buyer in Q2 2017 was Ardsley Advisory Partners, an estimated $4.12M added.
- The largest Marrone Bio Innovations, Inc. seller in Q2 2017 was Bridgeway Capital Management, an estimated $37.3K sold.
Based on aggregated 13F filings for Q2 2017.